About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 35 record(s)
Req # A-2021-024942
Provide all emails sent to/from/cc'ing Douglas Clarke between May 1 to December 16, 2021. Exclude media scans.Organization: Patented Medicine Prices Review Board Canada
September 2023
Req # A-2023-36126
When referring to page numbers below, I mean the pages in the Client Package disclosed under A-2022-05111. Specifically, I would like to request the following: 1. The "Board deck" (presumably a PowerPoint presentation) mentioned on pages 21-27. 2. The powerpoint attached to the email on page 47, which apparently deals with discrepancies between dTCC data. 3. The media lines attached to the email on page 95. 4. The excel sheet attached to the email on page 98. 5. The presentation attached to the email on page 135. 6. Both attachments to the email on page 135, plus the two documents that are linked to in the email: the impact estimates and communication plan. 7. The attachment to the email on page 142. 8. The "Key messages" document linked to in the body of the email on page 145. 9. The Excel file attached to the email on page 165. 10. I would like any contextual documents related to the document which appears on pages 359-360 ("Brochure: 2020 Rent Increase Guidelines). I imagine this was an attachment to an email, in which case I would like the email (possibly pages 4368-4369 of the raw request). I would also like to request any other documents related to how the brochure was located by the PMPRB, or what use was made of the Brochure by the PMPRB (like subsequent email discussions or meeting agendas which list this document, or reports or memos written about this document, etc). In each case, I would like the most recent or final version. I do not need drafts. Please exclude cabinet confidences.Organization: Patented Medicine Prices Review Board Canada
September 2023
Req # A-2022-00040
All records produced, sent or received by the Public Prosecution Service of Canada (PPSC) between July 24, 2020, and September 6, 2022, concerning the advisability of continuing, suspending or abandoning the appeal to the Supreme Court of Canada of the decision in R. v. Sharma, 2020 ONCA 478, handed down by the Court of Appeal for Ontario. As well as the legal consequences for the PPSC of this decision, including the conduct of PPSC business or any changes to PPSC directives or policies in response to this decision.Organization: Public Prosecution Service of Canada
September 2023
Req # A-2022-01918
Copies of the number of every patent reported to the PMPRB, via Form 1 Patent List or otherwise, with respect to Keytruda pembrolizumab.Organization: Patented Medicine Prices Review Board Canada
September 2022
Req # A-2022-00004
Copy of all communications sent and received by Kathleen Roussel, Director of Public Prosecutions, André Morin, Chief Federal Prosecutor of the Quebec Regional Office, David Antonyshyn and George Dolhai, Deputy Directors of Public Prosecutions and Richard Roy, Senior General Counsel, related to the “secret trial” or “ghost trial” or “designated person record” between March 25, 2022, and April 6, 2022.Organization: Public Prosecution Service of Canada
September 2022
Req # A-2022-00032
Complete copy of any document showing a list of all cases reported by PPSC to the Attorney General because they raised significant issues of public interest, between January 1, 2019, and August 22, 2022.Organization: Public Prosecution Service of Canada
September 2022
Req # A-2022-00038
Briefing note 2022-0405 entitled: "Report of a privacy breach contrary to the Privacy Act".Organization: Public Prosecution Service of Canada
September 2022
Req # A-2021-10624
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and AstraZeneca Canada over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 7, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
September 2021
Req # A-2021-10628
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and ALS/SLA Action Canada over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 7, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
September 2021
Req # A-2021-10633
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Astellas Pharma Canada over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 7, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
September 2021